Viewing Study NCT05734066


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-02-03 @ 10:20 AM
Study NCT ID: NCT05734066
Status: RECRUITING
Last Update Posted: 2025-01-23
First Post: 2023-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Sponsor: Jazz Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Ewing Sarcoma View
None Relapsed Ewing Sarcoma View
None Ewing Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None lurbinectedin View
None ewing's sarcoma View
None soft tissue sarcoma View
None sarcomas View